Latest & greatest articles for menopause

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on menopause or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on menopause and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for menopause

21. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.

Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. BACKGROUND: Mutations in the gene encoding mitochondrial DNA polymerase gamma (POLG), the enzyme that synthesises mitochondrial DNA (mtDNA), have been associated with a mitochondrial disease-autosomal dominant or recessive progressive external ophthalmoplegia-and multiple deletions of mtDNA. Mitochondrial dysfunction is also suspected to participate in the pathogenesis (...) and positron emission tomography (PET). FINDINGS: We recorded mutations in POLG in members of all seven families. Clinical assessment showed significant cosegregation of parkinsonism with POLG mutations (p<0.0001), and PET findings were consistent with dopaminergic neuron loss. Post-mortem examination in two individuals showed loss of pigmented neurons and pigment phagocytosis in substantia nigra without Lewy bodies. Furthermore, most women with progressive external ophthalmoplegia had early menopause

Lancet2017

26. Non-Pharmacologic Treatments for Vasomotor Symptoms Associated with Menopause

Non-Pharmacologic Treatments for Vasomotor Symptoms Associated with Menopause Management Briefs Search the HSR&D website Button to search HSRD ® Inside VA Budget and Performance Inside the News Room National Observances Special Events » » » » » Management Briefs Health Services Research & Development Management Brief no. 117 » Issue 117 October 2016 The systematic review reported on here is a product of the VA/HSR&D Quality Enhancement Research Initiative (QUERI) Evidence-Based Synthesis (...) Program. Evidence Report: Non-Pharmacologic Treatments for Vasomotor Symptoms Associated with Menopause Vasomotor symptoms (VMS), which include hot flashes and night sweats, are the most common symptoms reported during the menopausal transition. VMS symptoms are experienced by as many as 80% of women with a mean age of onset of 51 years, and can last more than seven years. VMS can lead to increased healthcare encounters for symptom relief and reductions in quality of life. The degree to which VMS

Veterans Affairs - R&D2016

27. Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond

Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond DEFINE_ME_WA This site requires Cookies to be enabled to function. Please ensure Cookies are turned on and then re-visit the desired page.

Society of Obstetricians and Gynaecologists of Canada2016

28. Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis

Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis 27421538 2016 08 16 2017 02 20 1526-632X 87 7 2016 Aug 16 Neurology Neurology Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis. 699-708 10.1212/WNL.0000000000002980 To test the hypothesis that effects of estrogen-containing hormone therapy on cognitive abilities differ between postmenopausal women near to, and further from, menopause. In this randomized, double (...) -blind, placebo-controlled trial, healthy women within 6 years of menopause or 10+ years after menopause were randomly assigned to oral 17β-estradiol 1 mg/d or placebo. Women with a uterus received cyclic micronized progesterone vaginal gel or placebo. The primary outcome assessed at 2.5 and 5 years, compared between treatment groups, was change in a standardized composite of neuropsychological test scores assessing verbal episodic memory. Secondary outcomes assessed executive functions and global

EvidenceUpdates2016

29. Menopause Management - Getting Clinical Care Back on Track.

Menopause Management - Getting Clinical Care Back on Track. Menopause Management--Getting Clinical Care Back on Track. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26962899 Format MeSH and Other Data E-mail (...) Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2016 Mar 3;374(9):803-6. doi: 10.1056/NEJMp1514242. Menopause Management--Getting Clinical Care Back on Track. 1 , 1 . 1 From the Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston (J.E.M.); and the University of Florida College of Medicine, Jacksonville (A.M.K.). PMID: 26962899 DOI

NEJM2016

30. Acupuncture for Menopausal Hot Flashes: A Randomized Trial.

Acupuncture for Menopausal Hot Flashes: A Randomized Trial. 26784863 2016 02 02 2016 06 13 2017 04 18 1539-3704 164 3 2016 Feb 02 Annals of internal medicine Ann. Intern. Med. Acupuncture for Menopausal Hot Flashes: A Randomized Trial. 146-54 10.7326/M15-1380 Hot flashes (HFs) affect up to 75% of menopausal women and pose a considerable health and financial burden. Evidence of acupuncture efficacy as an HF treatment is conflicting. To assess the efficacy of Chinese medicine acupuncture against (...) sham acupuncture for menopausal HFs. Stratified, blind (participants, outcome assessors, and investigators, but not treating acupuncturists), parallel, randomized, sham-controlled trial with equal allocation. (Australia New Zealand Clinical Trials Registry: ACTRN12611000393954). Community in Australia. Women older than 40 years in the late menopausal transition or postmenopause with at least 7 moderate HFs daily, meeting criteria for Chinese medicine diagnosis of kidney yin deficiency. 10

Annals of Internal Medicine2016

32. Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer

Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer Prescrire IN ENGLISH - Spotlight ''Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer'', 1 January 2016 {1} {1} {1} | | > > > Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |    (...) |   |   |   |  Spotlight Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer The harm-benefit balance for hormone replacement therapy in menopause is unfavourable due to an increased risk of cardiovascular disease and of breast cancer. It also exposes women to ovarian cancer. At the beginning of 2015, a review of 52 epidemiological studies showed a statistically significant risk of ovarian cancer in women exposed to menopausal

Prescrire2016

33. Examining the psychometric properties of the brief 'Menopausal Symptoms Distress Affecting Sleep Quality Scale'

Examining the psychometric properties of the brief 'Menopausal Symptoms Distress Affecting Sleep Quality Scale' 26388508 2016 01 15 2016 09 21 2016 01 15 1365-2702 24 23-24 2015 Dec Journal of clinical nursing J Clin Nurs Examining the psychometric properties of the brief 'Menopausal Symptoms Distress Affecting Sleep Quality Scale'. 3654-63 10.1111/jocn.12958 To examine the psychometric properties of the Menopausal Symptoms Distress Affecting Sleep Quality Scale. Sleep disturbances (...) are an extensive and common problem among menopausal women. However, no unique and specific scale has yet been developed to detect the inductive symptoms distresses that cause poor sleep quality for menopausal women. A cross-sectional design. The Menopausal Symptoms Distress Affecting Sleep Quality Scale was based on in-depth interviews with menopausal women and literature review. Convenience sampling was employed. One hundred and fifty three women participated in this study. Exploratory factor analysis

EvidenceUpdates2015

34. Limited Evidence Suggests Oral Health Providers Should Observe Caution When Treating Post-Menopausal Women Taking Aromatase Inhibitor (AI) Drugs or Estrogen Modulating Agents

Limited Evidence Suggests Oral Health Providers Should Observe Caution When Treating Post-Menopausal Women Taking Aromatase Inhibitor (AI) Drugs or Estrogen Modulating Agents UTCAT2949, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Limited Evidence Suggests Oral Health Providers Should Observe Caution When Treating Post-Menopausal Women Taking Aromatase Inhibitor (AI) Drugs or Estrogen Modulating Agents Clinical (...) Question Is there an increased risk of alveolar bone loss and dental-related complications in post-menopausal women taking aromatase inhibitor drugs or estrogen/progesterone modulator agents? Clinical Bottom Line Special consideration should be taken regarding the treatment of post-menopausal women taking aromatase inhibitor (AI) drugs. In particular, this includes monitoring periodontal disease, patients undergoing dentoalveolar surgery, and monitoring bone density. Evidence suggests appreciable loss

UTHSCSA Dental School CAT Library2015

35. Periodontal treatment outcomes in post menopausal women receiving hormone replacement therapy

Periodontal treatment outcomes in post menopausal women receiving hormone replacement therapy 39 PERIODONTAL TREATMENT OUTCOMES IN POST MENOPAUSAL WOMEN RECEIVING HORMONE REPLACEMENT THERAPY Hormon Replasman Tedavisi Alan Postmenopozal Dönemdeki Kadinlarda Periodontal Tedavinin Etkileri Ali ÇEKICI 1 , Ülkü BASER 1 , Gülden ISIK 1 , Süleyman E. AKHAN 2 , Halim ISSEVER 3 , Utku ONAN 1 Received: 05/08/2015 Accepted:20/10/2015 ABSTRACT Purpose: To evaluate the effect of hormone (...) replacement therapy(HRT) on periodontal treatment outcomes in a group of postmenopausal women with periodontitis. Materials and Methods: 23 post-menopausal chronic periodontitis patients were included in this study. The test group(n=11) consisted of women who started HRT with this study and received conjugated estrogen and medroxyprogesteron. The control group(n=12) was women not taking any HRT or supplement therapy. Study groups received the same periodontal treatment. All subjects examiend by recording

Journal of Istanbul University Faculty of Dentistry2015 Full Text: Link to full Text with Trip Pro

36. No sex please, we’re menopausal!

No sex please, we’re menopausal! No sex please, we're menopausal! - Evidently Cochrane Search and hit Go By March 13, 2015 // In today’s guest blog, Elaine Miller, a physiotherapist who also does a stand-up comedy show about pelvic floors, tackles sex and the menopause. I have a faded post-it note on my office wall that says “what most people need is a really good listening to”. It’s sound advice for life, but, particularly useful whenever a patient brings up a sexual function issue in clinic (...) . Menopausal women often experience changes in how they think about their bodies and sexuality. Many have sad feelings about the loss of fertility and the body of their youth. Of course, some women relish not fearing unwanted pregnancy and finally feeling comfortable in their own skin. Elaine Miller, tackling the taboo with humour and reliable information. Sexuality is not just about having sex, and sex is about more than penetration. A lack of intimacy, in whatever form, negatively impacts our wellbeing

Evidently Cochrane2015

37. Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe?

Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe? Hormone Therapy for the Menopause after Endometriosis Surgery - Friend or Foe? - Evidently Cochrane Search and hit Go By March 12, 2015 // In today’s guest blog, Dr Martin Hirsch explains about endometriosis and treatment choices for women who have the menopause induced because of it. It’s Menopause Week here at Evidently Cochrane and as a team including individual bloggers, Cochrane UK, Healthtalk and Menopause UK (...) with their NHS Change Day campaign to ‘Change the Change’, we are summarising the evidence surrounding the menopause to ensure women get the correct facts from reliable evidence. This blog aims to help women who have had the menopause induced through surgery for endometriosis make more informed health decisions at a time of significant change for their mind and body. Endometriosis – what is it and how do I know if I have it? Most women have heard of the menopause. They fear it, but for a select few

Evidently Cochrane2015

38. Everything I needed to know about the menopause… No One Told Me

Everything I needed to know about the menopause… No One Told Me Everything I needed to know about the menopause... No One Told Me - Evidently Cochrane Search and hit Go By March 11, 2015 // Today’s guest blog comes from Oxford academic June Girvin, who shares her experiences of the menopause, the taboo and the information gap. Today is NHS Change Day and June, along with the rest of our guest bloggers in this special series on the menopause, is backing Menopause UK’s grassroots campaign (...) for Change Day to #changethechange. You can read more about that . It’s Menopause Week on Evidently Cochrane. I wasn’t sure whether that required an exclamation mark, but decided, all things considered, that it didn’t. My contribution to this week of menopause related blogs is a personal one – or a phenomenological one as this is a blog for ‘Evidently Cochrane’ – and I think my lived experience of the ‘last taboo’ or the ‘Big M’ (thankfully one rarely hears it called ‘THE CHANGE’ anymore with all its

Evidently Cochrane2015

39. Let’s talk about the menopause

Let’s talk about the menopause Let's talk about the menopause - Evidently Cochrane Search and hit Go By March 6, 2015 // In the first of our series of guest blogs about the menopause and health, Jenny Hislop , a Senior Qualitative Researcher in the (HERG) at the University of Oxford, talks about her research on the menopause and collecting women’s stories for the website. The website “brings the menopause into the open.” A few years ago I had the privilege of interviewing 46 women throughout (...) the UK about their experiences of the menopause for the award-winning website What impressed me most was their willingness to talk openly about the menopause and its impact on their everyday lives. And it takes courage to do this. We live in a society where we tend to build a wall of silence around personal matters like the menopause – it’s something we keep hidden and as a result no one really knows what to expect. And I think this is one of the key strengths of the menopause site: it brings

Evidently Cochrane2015

40. Making sense of the menopause: experience, evidence and you

Making sense of the menopause: experience, evidence and you Making sense of the menopause: experience, evidence and you - Evidently Cochrane Search and hit Go By March 6, 2015 // Let’s talk about the menopause. We really need to! We’ve designated next week Menopause Week on Evidently Cochrane and this afternoon we start a series of six guest blogs on the menopause, from women brave enough to share their experiences and doctors and researchers with the latest evidence on treatments. We’re also (...) supporting in their actions for NHS Change Day on March 11th which they hope will #changethechange. It’s unthinkable that we wouldn’t tell girls about menstruation, yet this other stage in women’s lives is not freely discussed and women are arriving at it unprepared. This isn’t so in all cultures and in those where aging conveys status the menopause is often treated rather differently. Louise Foxcroft has noted, in her excellent book on the modern menopause, that modern Jewish Orthodox practice has begun

Evidently Cochrane2015